Your body remembers common cold coronaviruses from childhood. How can you get the same immunity to COVID-19?
LA JOLLA, CA—For a glimpse into the future of SARS-CoV-2 immunity, scientists at La Jolla Institute for Immunology (LJI) are
LJI scientists publish first head-to-head comparison of four COVID-19 vaccines
Correction: A previous version of this article incorrectly stated that “Participants given the Janssen/J&J vaccine had the highest percentage of
Op-Ed: What will it take to make a universal COVID vaccine?
As California emerges from Omicron, other places are again in lockdown or facing record caseloads after trying and failing to
Current vaccines teach T cells to fight Omicron
Four COVID-19 vaccines prompt the body to make effective, long-lasting T cells against SARS-CoV-2.
LJI and Charles River Laboratories to collaborate on COVID-19 research
New agreement paves the way for better mouse models to study how the human immune system fights SARS-CoV-2
Our Bodies’ Best Shot Against Omicron Is an Army of Disgusting Murderers
When a T cell makes up its mind to kill, it does not mess around.
New vaccine ingredient shows promise
Most vaccines include particles called adjuvants. But not all adjuvants are created equal.
COVID-19 case severity: How genetic differences leave immune cells at a disadvantage
New LJI research shows how a range of critical immune cells respond to SARS-CoV-2
Six LJI scientists named “Highly Cited Researchers”
The international recognition reflects how LJI research is valued by scientific peers
Erica Ollmann Saphire receives $2.6 million grant to collaborate on pan-coronavirus vaccine
La Jolla Institute scientists team up with Brigham and Women's Hospital to guide the development of vaccines against the coronavirus family
Beauty in science
Mexican sculptor assembles an emotional tribute to COVID-19 research
Lungs of COVID-19 survivors teem with virus-fighting ‘memory’ cells
Even elderly survivors show a strong, persistent immune memory